Muto Taro, Okazaki Il-mi, Yamada Shuichi, Tanaka Yoshimasa, Kinoshita Kazuo, Muramatsu Masamichi, Nagaoka Hitoshi, Honjo Tasuku
Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan.
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2752-7. doi: 10.1073/pnas.0510970103. Epub 2006 Feb 13.
Both class switch recombination (CSR) and somatic hypermutation (SHM) of the Ig genes require the activity of activation-induced cytidine deaminase (AID). Expression of AID is restricted to B cells in the germinal centers of the lymphoid organs, where activated B cells undergo CSR and SHM. We previously showed that constitutive and systemic expression of AID leads to tumorigenesis in T cells and lung epithelium, but not in B cells. This finding led us to suspect that transgenic AID may be inactivated at least in part in B cells. To address this issue, we generated conditional AID-transgenic mice that constitutively express AID only in B cells. Studies on the cross between the AID-transgenic and AID-deficient mice showed that abundant AID protein accumulated by constitutive expression is inactivated in B cells, possibly providing an explanation for the absence of deregulation of CSR and SHM in AID-transgenic B cells.
免疫球蛋白基因的类别转换重排(CSR)和体细胞高频突变(SHM)都需要激活诱导的胞嘧啶脱氨酶(AID)的活性。AID的表达仅限于淋巴器官生发中心的B细胞,在那里活化的B细胞会发生CSR和SHM。我们之前表明,AID的组成型和全身性表达会导致T细胞和肺上皮细胞发生肿瘤,但不会导致B细胞发生肿瘤。这一发现使我们怀疑转基因AID在B细胞中可能至少部分失活。为了解决这个问题,我们构建了条件性AID转基因小鼠,其仅在B细胞中组成型表达AID。对AID转基因小鼠和AID缺陷小鼠杂交后代的研究表明,组成型表达积累的大量AID蛋白在B细胞中失活,这可能解释了AID转基因B细胞中CSR和SHM未发生失调的原因。